Measures for batch issuance of biological products

The State Administration of market regulation promulgated the measures for the administration of batch issuance of biological products, which shall come into force on March 1, 2021. The national medical product administration-NMPA shall be responsible for the batch issuance of biological products nationwide and the on-site inspection. The national institutes for food and drug control-NIFDC organizes the formulation of technical requirements and assessment rules for batch issuance of biological products. The applicant shall establish a template for the summary of batch issuing production and inspection records of each variety. After the production and inspection of the product are completed, theRead More →

Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is $5,500 Best! Paolo yue Email: Cell: 008613501397114

Existing Users Log In
New User Registration
*Required field